Results Healthcare advised Ajinomoto Bio-Pharma Services on the licencing of its Crystalomics Formulation Technology to Kyowa Kirin

  • Service: Licensing
  • Sector: Healthcare
  • Sub Sector: Pharma & Biotech
  • Engagement Type: Buy Side
Mar 2021
has licensed the patents and know-how to its Crystalomics Formulation Technology to

Sector Related Deals

May 2021
has formed a strategic alliance with
Jan 2021
has divested its Mirabel manufacturing site in Riom, France to
Jan 2021
has divested its Ringaskiddy analytics and testing site to
Oct 2020
has divested its Poznań, Poland manufacturing site to
Sep 2020
has divested its Barcelona manufacturing sites to
Sep 2020
has divested its Segré, France manufacturing facility to
May 2020
has acquired
Mar 2020
has divested its Mississauga, Ontario manufacturing facility to
Mar 2020
has divested its Alprostadil products to